E
Adverum Biotechnologies, Inc. ADVM
$3.08 $0.051.65% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -61.29% -73.20% -111.16% 17.49% 3.21%
Total Depreciation and Amortization -44.04% -31.49% -19.72% -41.02% -37.68%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -68.90% -38.02% 121.04% -69.61% -13.68%
Change in Net Operating Assets 277.71% 108.60% 330.86% 187.00% 189.69%
Cash from Operations -95.36% -84.00% -32.45% 11.66% 14.65%
Capital Expenditure -650.00% -144.44% 68.23% 55.35% 55.56%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 1,485.72% 243.59% 57.38% -170.22% -103.45%
Cash from Investing 1,471.04% 242.01% 57.59% -173.34% -103.47%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -1.24% -100.00% --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 203.45% -- 43.98% 100.00% -1,550.00%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 69.74% -115.40% -3.73% -492.17% -150.90%